Sanofi-Aventis Pakistan Limited Pharmaceuticals vs. Glaxosmithkline
Abstract
Effects of Quality Management on Domestic and Global Competition
In Pakistan, Sanofi-Aventis and GlaxoSmithKline are pharmaceutical companies that market popular products and carry very similar medications. Companies like these have the mission and responsibility of providing medicines and vaccinations to better people’s live in different countries and communities. One of the largest and leading pharmaceutical companies in Pakistan is the Sanofi-Aventis Pakistan Limited. The chains put most of their focus on therapeutic areas such as: cardiovascular, thrombosis, oncology, central nervous systems function, metabolic disorders, internal medicine, and vaccinations (Sanofi, 2010). GlaxoSmithKline is also known for developing some of the nation’s leading global medicines in the fields of HIV/AIDS, tuberculosis, and malaria. The strategic management methods this manufacturer has chosen to use has made them a leader in the industry, among its competitors with respect to changing markets and growth trends. In 2007, the number one rated pharmaceutical company was GlaxoSmithKline, which has fount its continued success in making very wise business decisions like delivering almost 1 billion vaccines to developing countries in 2009 (GlaxoSmithKline, 2010).
Diseases such as cardiovascular issues, thrombosis, cancer, diabetes, HIV/AIDS, malaria, and other major illnesses have been crucial public health issues for Pakistan because they have been proven to be a main contributor to the total global mortality rates. It is for this reason that companies like Sanofi-Aventis and GlaxoSmithKline have concentrated so much of their research efforts on those specific issues and areas. The result has resulted in a world-renowned reputation of expertise for both in the industry. The following paper will explain why the medications that are produced by the companies above are competitive in both domestic and global markets, and it will compare and contrast the quality
Effects of Quality Management on Domestic and Global Competition
In Pakistan, Sanofi-Aventis and GlaxoSmithKline are pharmaceutical companies that market popular products and carry very similar medications. Companies like these have the mission and responsibility of providing medicines and vaccinations to better people’s live in different countries and communities. One of the largest and leading pharmaceutical companies in Pakistan is the Sanofi-Aventis Pakistan Limited. The chains put most of their focus on therapeutic areas such as: cardiovascular, thrombosis, oncology, central nervous systems function, metabolic disorders, internal medicine, and vaccinations (Sanofi, 2010). GlaxoSmithKline is also known for developing some of the nation’s leading global medicines in the fields of HIV/AIDS, tuberculosis, and malaria. The strategic management methods this manufacturer has chosen to use has made them a leader in the industry, among its competitors with respect to changing markets and growth trends. In 2007, the number one rated pharmaceutical company was GlaxoSmithKline, which has fount its continued success in making very wise business decisions like delivering almost 1 billion vaccines to developing countries in 2009 (GlaxoSmithKline, 2010).
Diseases such as cardiovascular issues, thrombosis, cancer, diabetes, HIV/AIDS, malaria, and other major illnesses have been crucial public health issues for Pakistan because they have been proven to be a main contributor to the total global mortality rates. It is for this reason that companies like Sanofi-Aventis and GlaxoSmithKline have concentrated so much of their research efforts on those specific issues and areas. The result has resulted in a world-renowned reputation of expertise for both in the industry. The following paper will explain why the medications that are produced by the companies above are competitive in both domestic and global markets, and it will compare and contrast the quality